Filler,withapapertrail.

Hyaluronic acid filler does not metabolise at the rate marketing materials suggest. The manufacturer data — "Juvéderm Voluma lasts up to 2 years" — is true in aggregate but misleading in detail. Two years is the point at which roughly half the product is gone. The other half remains. Twelve months later, maybe 30% is still present. Eighteen months after that, meaningful residual volume can still be measurable in the treated zone.

If a client returns at 18 months for a "top-up" and the injector adds a full syringe without referencing what remains, the face now carries roughly 1.3 syringes of volume in that zone. Stack that pattern across cheek, jawline, tear trough, and lip over five years, and you arrive at the phenomenon that's become visible on camera — the subtly wide, slightly distorted faces that photograph differently than they did at 35.

This is not a theoretical worry. It is the single most common reason I have a client come in requesting hyaluronidase reversal. They never "asked" to be over-filled. It happened one syringe at a time over many years, each visit approved by an injector who wasn't tracking cumulative volume.

At Bravo, your volume log opens on the intake screen at every visit. I see what was placed, where, when, and what the running total is in each zone. If the total in a zone has reached my clinical threshold, we dissolve before we re-inject. Sometimes that means no filler at today's appointment. You will be told. You will agree with the decision or you will leave without filler — which is a perfectly reasonable outcome.

A cannula is a blunt-tipped, flexible instrument. It enters through one small needle-made entry point and then moves laterally through the tissue plane without puncturing vessels. It's the technique I default to for cheek, jawline, tear trough, and nasolabial work.

The primary safety advantage is vascular. Filler injected inadvertently into an artery is how the rare but catastrophic complications happen — tissue necrosis, vision loss in the worst reported cases. A cannula dramatically reduces the risk of intra-arterial injection because its blunt tip tends to push vessels aside rather than puncture them. The risk is not zero, but it is closer to zero than needle injection in the same zones.

The secondary advantage is bruising. Needle injection punctures every time the point advances; cannula places the entry bruise once and threads through subsequent zones. Clients who've had both techniques on the same face usually tell me the cannula side bruised less.

For zones where precision outweighs these advantages — the lip vermillion border, chin projection, small perioral corrections — I use a 30-gauge fine needle. Anatomy dictates tool. Not preference, not speed.

Single syringe (standard Juvéderm or Restylane): $700. Most zones use 1 mL; lips often use 0.5 mL for first-timers.

Half-syringe lip starter: $425. The dose I recommend for most first-time lip clients. Enough to see the effect without committing you to a look you haven't lived with yet.

Two-syringe same-visit plan: $1,350. Saves $50 per syringe. Most common: cheek + jawline, cheek + chin, or dual-zone lip and perioral.

RHA (Revance) premium series: from $900/syringe. My pick for motion-heavy zones — nasolabial, perioral — where the longer duration and dynamic behaviour justify the price.

Biostimulators (Sculptra, Radiesse): see our biostimulator page for detailed pricing and how they differ from HA filler.

Every price includes the 60-minute initial consultation, the placement session, a 2-week written review, and any micro-adjustment using residual product that day. You will see a written total before anything is injected. There are no upsell add-ons.